You are viewing an incomplete version of our website. Please click to reload the website as full version.

Goat anti-Human IgG (Fc Region) Antibody

Details for Product No. ABIN101643, Supplier: Log in to see
Antigen
Epitope
Fc Region
4372
1724
1659
896
804
618
560
279
35
34
31
8
8
5
3
3
2
2
2
2
2
2
1
1
1
1
1
1
Reactivity
Human
2652
2595
2291
1654
1388
734
606
416
348
336
332
325
306
259
165
148
118
112
40
27
21
21
12
8
7
5
5
5
4
4
4
4
4
4
4
4
4
3
3
2
2
1
1
1
1
Host
Goat
6508
4552
1744
764
646
367
93
51
50
8
8
5
4
3
1
1
Clonality
Polyclonal
Application
Immunoassay (IA)
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Immunogen Human IgG fragment
Specificity IgG F(c)
Characteristics Concentration Definition: by Refractometry
Purification This product was prepared from monospecific antiserum by a delipidation and defibrination. Assay by immunoelectrophoresis resulted in a single precipitin arc against Human IgG, Human IgG F (c) and Human Serum.
Research Area Immunology, Secondary Antibodies
Application Notes Optimal working dilutions should be determined experimentally by the investigator.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Restore with deionized water (or equivalent)
Concentration 31.0 mg/mL
Buffer 0.01 M Sodium Phosphate, 0.15 M Sodium Chloride, pH 7.2
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Background publications Jarrett, Gallagher, Jones, Alexander, Krajewski, Kelsey, Adams, Angus, Gledhill, Wright: "Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age." in: Journal of clinical pathology, Vol. 44, Issue 10, pp. 844-8, 1992 (PubMed).

Fahraeus R,Fu HL,Ernberg I,Finke J,Rowe M,Klein G,Falk K,Nilsson E,Yadav M,Busson P: "Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma." in: Int J Cancer, Vol. 42, Issue 3, pp. 329-38, 1988 (PubMed).

Rowe, Evans, Young, Hennessy, Kieff, Rickinson: "Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells." in: The Journal of general virology, Vol. 68 ( Pt 6), pp. 1575-86, 1987 (PubMed).

Papadea, Check, Reimer: "Monoclonal antibody-based solid-phase immunoenzymometric assays for quantifying human immunoglobulin G and its subclasses in serum." in: Clinical chemistry, Vol. 31, Issue 12, pp. 1940-5, 1986 (PubMed).

Robinson, White, Mason: "Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3." in: Immunology, Vol. 57, Issue 2, pp. 239-47, 1986 (PubMed).

Reimer, Phillips, Aloisio, Moore, Galland, Wells, Black, McDougal: "Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes." in: Hybridoma, Vol. 3, Issue 3, pp. 263-75, 1985 (PubMed).